Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone

Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone

The hyperinflammatory phase represents the main cause for the clinical worsening of acute respiratory distress syndrome (ARDS) in Coronavirus disease 2019 (COVID-19), leading to the hypothesis that steroid therapy could be a mainstream treatment in COVID-19 patients. This is an observational study i...

Full description

Bibliographic Details
Main Authors: Alessandro Russo, Chiara Davoli, Cristian Borrazzo, Vincenzo Olivadese, Giancarlo Ceccarelli, Paolo Fusco, Alessandro Lazzaro, Rosaria Lionello, Marco Ricchio, Francesca Serapide, Bruno Tassone, Elio Gentilini Cacciola, Claudio Maria Mastroianni, Carlo Torti, Gabriella d’Ettorre, Enrico Maria Trecarichi
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Biomedicines
Subjects:
SARS-CoV-2
COVID-19
dexamethasone
methylprednisolone
mortality
Online Access:https://www.mdpi.com/2227-9059/10/7/1548

Internet

https://www.mdpi.com/2227-9059/10/7/1548

Similar Items